RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alheimer's disease: A systematic review and meta-analysis.
Hansen, RA., Gartlehner, G., Webb, AP., Morgan, C., & Moore, C. (2008). Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alheimer's disease: A systematic review and meta-analysis.Clinical Interventions in Aging, 3(2), 1 - 15.
